United Kingdom · Question · Written question
UIN 77063
Rare Diseases: Drugs
Introduced
15 September 2025
Last action
13 October 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 October 2025
Summary
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of NHS England providing formal agreements in principle to pharmaceutical companies that commercial flexibility may be granted for
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 September 2025
Written question
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of NHS England providing formal agreements in principle to pharmaceutical companies that commercial flexibility may be granted for
Source: Commons
13 October 2025
Answer
I refer the Hon. Member to the answers my Rt Hon. Friend, the Minister of State for Health gave on 1 September 2025 to Questions 69240, 69241, and 69242.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-15/77063
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1834922
- uk · wq-1834922 · source updated 13 October 2025